Cross-sectional surveillance study on pneumococcal serotypes and other pathogens in nasopharyngeal samples from infants and parents performed 6.5 years after introduction of pneumococcal vaccination in The Netherlands.
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2013
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms OKIDOKI-3
- 26 Sep 2012 Planned End Date changed from 3 Feb 2013 to 3 Mar 2013 as reported by Netherlands Trial Register record.
- 26 Sep 2012 New source identified and integrated (Netherlands Trial Register; NTR3614).
- 17 Sep 2012 New trial record